InsiderTrades

Form 4 for ELV Elevance Health

Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0002084548-26-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-03-04 2026-03-03 ELV Wessling Erin M EVP, CLO F - Tax $284.03 -417 7,579 -5% -$118.4K
D 2026-03-04 2026-03-02 ELV Wessling Erin M EVP, CLO A - Grant $0.00 +2,976 7,996 +59% $0
D 2026-03-04 2026-03-02 ELV Wessling Erin M EVP, CLO A - Grant $0.00 +11.8K 11.8K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-03 F D 417 $284.03 7,579 D — — (F2) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
2 Common Common Stock 2026-03-02 A A 2,976 $0.00 7,996 D — — (F1) Represents restricted share units. Restrictions lapse as follows: 992 shares on 3/2/2027, 3/2/2028 and 3/2/2029.
3 Derivative Employee Stock Option (Right to Buy) 2026-03-02 A A 11,754 $0.00 11,754 D $294.07 · — to 2036-03-02 11,754 Common Stock (F3) The option represents a right to purchase a total of 11,754 shares, and is exercisable in three annual installments, each installment of 3,918 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.